Decision
New rules for proving the equivalence of chemical medicines in Argentina
ANMAT has updated the regulatory framework for proving the therapeutic equivalence of chemical medicines.
If you use or manufacture chemical medicines in Argentina, this new regulation from ANMAT changes how therapeutic equivalence is proven for multi-source drugs. The government has approved a new framework to update the quality, safety, and efficacy requirements for these medicinal specialties.
What we do not know: the specific technical details of the new requirements for each type of chemical synthesis or how this transition affects medicines already on the market.
Headlines and summaries are written by AI for Outer News (RS Elite Pro s.r.o.) from the official text and are not reviewed by a person. They are not the official text and can contain mistakes: before you rely on one, read the original.
Original title: La ANMAT actualizó el marco regulatorio para demostrar la equivalencia terapéutica de medicamentos
Read the official decisionSource: Ministry of Justice (SAIJ)